• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

Latest Research Brief on 4-Fluorobenzyl-2,3,5,6-d4-amine (CAS: 1219798-96-5) in Chemical Biology and Pharmaceutical Applications

The compound 4-Fluorobenzyl-2,3,5,6-d4-amine (CAS: 1219798-96-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique deuterated structure and potential applications in drug development and metabolic studies. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, characterization, and emerging applications in medicinal chemistry.

Recent studies highlight the critical role of 4-Fluorobenzyl-2,3,5,6-d4-amine as a deuterated building block in the synthesis of isotopically labeled pharmaceuticals. The incorporation of deuterium atoms at the 2,3,5,6 positions of the benzyl ring enhances the metabolic stability of drug candidates, a property that is increasingly exploited in the development of novel therapeutics with improved pharmacokinetic profiles. Researchers have employed advanced techniques such as NMR spectroscopy and mass spectrometry to confirm the structural integrity and isotopic purity of this compound, which is essential for its application in tracer studies.

In the context of drug discovery, 4-Fluorobenzyl-2,3,5,6-d4-amine has been utilized as a key intermediate in the synthesis of fluorinated analogs of biologically active molecules. The presence of both fluorine and deuterium in its structure offers unique advantages, including increased lipophilicity and resistance to oxidative metabolism. Recent publications in journals such as the Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters have demonstrated its utility in the development of CNS-targeting drugs, where metabolic stability is paramount.

Furthermore, the compound's application in proteomics and metabolomics research has expanded significantly. Its deuterated nature makes it an ideal internal standard for quantitative mass spectrometry analyses, enabling precise measurement of drug metabolites and endogenous compounds in complex biological matrices. Recent methodological advancements have leveraged 4-Fluorobenzyl-2,3,5,6-d4-amine to improve the accuracy of pharmacokinetic studies, particularly in the investigation of first-pass metabolism and drug-drug interactions.

From a synthetic chemistry perspective, novel routes for the preparation of 4-Fluorobenzyl-2,3,5,6-d4-amine have been reported, focusing on improved yield and scalability. These developments are crucial for meeting the growing demand for high-quality deuterated compounds in pharmaceutical research. Recent patents have also highlighted its potential use in the formulation of deuterated drugs, particularly in areas such as oncology and neurology where metabolic stability can significantly impact therapeutic outcomes.

In conclusion, 4-Fluorobenzyl-2,3,5,6-d4-amine (CAS: 1219798-96-5) represents a versatile and valuable tool in modern pharmaceutical research. Its unique structural features and demonstrated applications in drug development, metabolic studies, and analytical chemistry underscore its importance in advancing chemical biology research. As the field continues to explore the benefits of deuteration in drug design, this compound is expected to play an increasingly prominent role in the development of next-generation therapeutics with optimized pharmacological properties.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)